budesonide nasal
Brand names: Rhinocort
Rhinocort is a nasal spray that helps relieve allergy symptoms. It contains budesonide, a type of steroid that reduces inflammation in your nose.
What it does
Rhinocort temporarily relieves allergy symptoms.
Common side effects
No common side effects listed.
Key warnings
The growth rate of some children may be slower while using this product.
How It Works
Budesonide is a steroid that reduces inflammation. When sprayed into your nose, it reduces swelling and irritation. This helps to relieve your allergy symptoms.
How to Take It
Before using a new bottle, you must prime it. If you haven't used the spray for two days, prime it again. For adults and children 12 and older, spray 2 times in each nostril once a day while sniffing gently. Once your symptoms improve, reduce to 1 spray in each nostril per day.
Pregnancy & Breastfeeding
There is no information about the safety of using this medication during pregnancy or breastfeeding in the provided data.
Missed Dose
If you forget a dose, do not double the next dose. Just take your next dose as scheduled.
Storage
Shake well before each use.
Serious Warnings
The growth rate of some children may be slower while using this product. If a child 6 to under 12 years of age needs to use the spray for longer than two months a year, talk to their doctor.
Common Questions
How do I prime the bottle?
How often should I use the spray?
What if my symptoms don't improve?
Can children under 6 use this?
What if I spray it in my eyes?
Can I use this for a cold?
Do I need to shake the bottle?
What if I miss a dose?
How should children 6 to under 12 years of age use this spray?
What should I do if my child needs to use the spray for longer than two months a year?
What drug class is budesonide nasal?
Is budesonide nasal safe during pregnancy?
Related Medications in Nasal Corticosteroid
Other drugs grouped near budesonide nasal — same-class peers and common alternatives.
azelastine
Astelin, Astepro
Azelastine nasal spray is an antihistamine medicine.
Compare with budesonide nasal →
cetirizine
Zyrtec
Cetirizine (Zyrtec) is an antihistamine medicine.
Compare with budesonide nasal →
chlorpheniramine
Chlor-Trimeton
Chlorpheniramine is an antihistamine medicine.
Compare with budesonide nasal →
ciclesonide nasal
Omnaris, Zetonna
Omnaris Nasal Spray is a medicine that helps treat allergy symptoms in your nose.
Compare with budesonide nasal →
desloratadine
Clarinex
Desloratadine is an antihistamine medicine.
Compare with budesonide nasal →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Pain Relievers Compared
NSAIDs vs acetaminophen — which OTC pain reliever to use
Narrow Therapeutic Index Drugs
Why some drugs demand precise dosing and monitoring
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Related Health & Safety Data
🩺 Find a Doctor
Search prescribers for Nasal Corticosteroid
🏨 Hospital Quality
CMS hospital ratings, safety scores & patient outcomes
💊 Supplement Data
NIH DSLD — check supplement ingredients & label claims
🍽️ Food Safety Alerts
FDA recalls, inspections & outbreak investigations
⚠️ Product Recalls
FDA, CPSC & NHTSA recall search
💉 Procedure Costs
Medicare procedure pricing for 9,297 procedures
What the FDA Data Shows for budesonide nasal
The FDA label for budesonide nasal (sold under brand names such as Rhinocort) classifies it as an over-the-counter product in the Nasal Corticosteroid class. Rhinocort temporarily relieves allergy symptoms. Labeling covers dosing, contraindications, and monitoring requirements derived from clinical trials.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. Interaction data is drawn directly from FDA-approved prescribing information. Acquisition-cost data is surveyed weekly by CMS and updated as manufacturers report changes.
Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.
Last updated: August 5, 2025
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- FDA Orange Book — approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed — NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) — post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm — standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files — federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database — current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages